Lv71
3640 积分 2025-01-10 加入
Potent in Vitro and In Vivo Efficacy of Hdz-C123A, a GSPT1 Degrader-Antibody Conjugate Targeting CD123 in Acute Myeloid Leukemia
1个月前
已完结
Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study
7个月前
已完结
A holistic view on c-Kit in cancer: Structure, signaling, pathophysiology and its inhibitors
7个月前
已完结
KIT as a therapeutic target for non-oncological diseases
7个月前
已完结
Anti‐KIT Barzolvolimab for Chronic Spontaneous Urticaria
7个月前
已完结
Inhibition of KIT for chronic urticaria: a status update on drugs in early clinical development
7个月前
已完结
Nemolizumab: First Approval
8个月前
已完结
皖公网安备34019202002308
